Calithera Biosciences, Inc(NASDAQ:CALA) 
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Its lead product candidate is CB-839, an inhibit...
Website: http://www.calithera.com
Founded: 2010
Full Time Employees: 92 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-01
P
O 0.00
H 0.00
L 0.00
C 0.00
V 2
10EMA
20EMA
60EMA
120EMA
250EMA